America February 5, 2026
Eikon’s Upsized $381M IPO Ignites Nasdaq Debut
Oncology-focused biopharmaceutical firm Eikon Therapeutics stepped onto the public stage Thursday, as Eikon’s Upsized $381M IPO powered its Nasdaq debut…
America February 5, 2026
Oncology-focused biopharmaceutical firm Eikon Therapeutics stepped onto the public stage Thursday, as Eikon’s Upsized $381M IPO powered its Nasdaq debut…
By Rachel Moore
America October 27, 2025
In a bold step that cements its place at the forefront of genetic medicine, Novartis AG announced Sunday that it…
By Rihem Akkouche
America October 14, 2025
In a bold move that strengthens its foothold in the rare disease and immunology market, BioCryst Pharmaceuticals Inc. announced Tuesday…
By Rihem Akkouche
America June 18, 2025
Draig Therapeutics Ltd., a rising star in neuropsychiatric drug development, has closed a $140 million Series A financing round, the…
By Rihem Akkouche
America June 16, 2025
In a strategic leap that fuses power with precision, Eaton Corp., the global power management titan, announced Monday it will…
By Rihem Akkouche
America June 27, 2024
Chicago-based pharmaceutical company AbbVie announced Thursday its acquisition of Celsius Therapeutics Inc., a privately held clinical-stage biotechnology firm focused on…
By Rihem Akkouche